secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2026-09-29T20:05:15+00:00
Accession:  0001104659-26-111920
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01
LLM model:  deepseek-v4.1-flash:cloud@v2

TELA Bio obtains lender consent to suspend minimum revenue covenant for two fiscal quarters
--------------------------------------------------------------------------------

- TELA Bio entered a Limited Consent to Credit Agreement and Guaranty on September 28, 2026 with Perceptive Credit Holdings V, LP and the Required Lenders.
- The Limited Consent provides that the Credit Agreement's Section 10.02 minimum Revenue covenant will not be tested for quarters ending on or about September 30, 2026 and December 31, 2026.
- The Credit Agreement and Guaranty is dated as of November 13, 2025, among TELA Bio, Perceptive Credit Holdings V, LP as administrative agent, and lenders party thereto.
- Heather Getz, Chief Executive Officer and Director, signed the report on September 29, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465926111920/0001104659-26-111920-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465926111920/tm2626521d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-111920

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer